GFM
TARS icon

GF Fund Management’s Tarsus Pharmaceuticals TARS Stock Holding History

GF Fund Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.9K Buy
953
+120
+14% +$8.38K ﹤0.01% 369
2025
Q4 		$68.2K Sell
833
-75
-8% -$5.6K ﹤0.01% 377
2025
Q3 		$54K Sell
908
-70
-7% -$3.45K ﹤0.01% 388
2025
Q2 		$39.6K Hold
978
– – ﹤0.01% 439
2025
Q1 		$50.2K Buy
978
+175
+22% +$8.65K ﹤0.01% 420
2024
Q4 		$44.5K Buy
+803
New +$36.5K ﹤0.01% 399

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return